← All stocks

Regeneron Pharmaceuticals

REGN Scheduled selling only

CIK 0000872589 #390 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$2.34M

$2.00M on a plan · $340.00K straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

−$2.34M

$0.00 against sales at will

By person

20 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

McCourt Marion

EVP Commercial

—

$2.00M (2) scheduled

−$2.00M

12,222

0.012%

$10.48M

−7.1%

Guarini Kathryn

Director

—

$340.00K (1) scheduled

−$340.00K

603

<0.001%

$517.01K

+113.8%

YANCOPOULOS GEORGE

Bd. Co-Chair, President & CSO

—

310,460

0.302%

$266.19M

+5.1%

SCHLEIFER LEONARD S

Bd. Co-Chair, President & CEO

—

214,523

0.209%

$183.93M

+8.9%

STAHL NEIL

EVP Research and Development

—

48,829

0.047%

$41.87M

−1.6%

MURPHY ANDREW J

EVP Research

—

47,833

0.047%

$41.01M

−1.0%

LAROSA JOSEPH J

EVP General Counsel and Secret

—

36,373

0.035%

$31.19M

+24.9%

SING GEORGE L

Director

—

31,007

0.030%

$26.59M

+18.0%

Van Plew Daniel P

EVP & General Mgr, Industrial

—

21,673

0.021%

$18.58M

+6.4%

Fenimore Christopher R.

EVP Finance CFO

—

19,984

0.019%

$17.13M

+30.6%

RYAN ARTHUR F

Director

—

17,303

0.017%

$14.84M

−2.1%

GOLDSTEIN JOSEPH L

Director

—

6,703

0.007%

$5.75M

+5.0%

POON CHRISTINE A

Director

—

5,219

0.005%

$4.47M

+140.3%

Pitofsky Jason

SVP Controller

—

4,272

0.004%

$3.66M

+1.6%

COLES N ANTHONY

Director

—

1,714

0.002%

$1.47M

+23.0%

Zoghbi Huda Y

Director

—

1,703

0.002%

$1.46M

+23.2%

Bassler Bonnie L

Director

—

1,703

0.002%

$1.46M

+23.2%

BROWN MICHAEL S

Director

—

1,703

0.002%

$1.46M

+23.2%

Thompson Craig B.

Director

—

775

<0.001%

$664.48K

+70.7%

Schenkein David P

Director

—

603

<0.001%

$517.01K

+113.8%

Individual transactions

Insider

Date

Role

Action

Price

Amount

LAROSA JOSEPH J

19 Aug 2026

EVP General Counsel and Secret

Exercised, kept

12,282

$381.92

$4.69M

Fenimore Christopher R.

18 Aug 2026

EVP Finance CFO

Exercised, kept

6,283

$381.92

$2.40M

Show all 5 transactions →

Regeneron Pharmaceuticals

By person

Individual transactions

What was left out